IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Summary

The goal of this clinical research study is to learn if IPI-145 can help to control the disease in patients with ALL. The safety of the study drug will also be studied.

Timeline

Start

2013-12

Primary completion

2016-12

Completion

—

Drugs

Indications